1. Revalidating pharmaceutical physicians

   Editorial 24 August 2012 Pages: 1 - 3

2. Recruitment Supplement

   • Robert N. Smith
   • Noel Snell

   Editorial 24 August 2012 Pages: 4 - 4

3. Principles and practice of pediatric drug development

   • Ronald E. Keeney

   Editorial 24 August 2012 Pages: 5 - 6

4. Re-think on paying for medicines

   Commentary 24 August 2012 Pages: 7 - 7

5. Hospitality fine

   News 24 August 2012 Pages: 9 - 9

6. Australian row over drug industry appointee

   News 24 August 2012 Pages: 9 - 9

7. NICE and Relenza — the saga continues (2)

   News 24 August 2012 Pages: 9 - 9

8. Announcements

   Announcement 24 August 2012 Pages: 10 - 10

   

9. The electroencephalogram (EEG)and clinical measures of opioid potency: defining the EEG-clinical potency relationship (‘fingerprint’) with application to remifentanil

   • Talmage D. Egan
   • K. T. Muir
   • S. L. Shafer

   Original Article 24 August 2012 Pages: 11 - 19

   

10. The bioequivalence of standard sumatriptan tablets and two encapsulated forms of sumatriptan

    • K. A. Milton
    • D. Kleinermans
    • J. D. H. Cooper

    Original Article 24 August 2012 Pages: 21 - 26

    

11. ‘High-profile’ product withdrawals in the United States

    • Anthony W. Fox

    Original Article 24 August 2012 Pages: 27 - 30

    

12. Annual Report of the Board of Examiners

    Education 24 August 2012 Pages: 31 - 33

    

13. Paediatric drug development: principles and practice

    • H. S. Boardman

    Meeting Report 24 August 2012 Pages: 35 - 47

14. Pharmacogenetics Working Party

    Society of Pharmaceutical Medicine 24 August 2012 Pages: 49 - 49

15. Future meetings

    Society of Pharmaceutical Medicine 24 August 2012 Pages: 49 - 49

16. Workplace

    BriefCommunication 24 August 2012 Pages: 50 - 50